Browse Items (3 total)
- Tags: Tanphaichitr Natthavat
Tags: *Gemcitabine, *Hemolytic uremic syndrome, *Pancreatic cancer, *Renal failure, *Thrombotic microangiopathy, 2018, Antibodies, Antimetabolites, Antineoplastic – Adverse Effects, Antineoplastic/*adverse effects, BMC nephrology, Das Abhijit, Deoxycytidine, Deoxycytidine – Adverse Effects, Deoxycytidine/adverse effects/*analogs & derivatives, Department of Internal Medicine, Female, Gupta Mohit, Humanized/*therapeutic use, Humans, Krishnappa Vinod, Middle Age, Middle Aged, Monoclonal, Monoclonal – Therapeutic Use, NEOMED College of Graduate Studies Student, NEOMED College of Medicine, Novak Robert, Raina Rupesh, Scales, Shah Haikoo, Tanphaichitr Natthavat, Thrombocytopenia – Chemically Induced, Thrombocytopenia – Diagnosis, Thrombocytopenia – Drug Therapy, Thrombotic Microangiopathies/*chemically induced/diagnosis/*drug therapy
Screening for nephropathy and antiangiotensin use among diabetic patients in an academic community medical center.
Tags: *Guideline Adherence, 2006, Academic Medical Centers, Age Factors, Aged, American journal of therapeutics, Angiotensin II Type 1 Receptor Blockers/*administration & dosage/therapeutic use, Angiotensin-Converting Enzyme Inhibitors/*administration & dosage/therapeutic use, Bourguet Claire C, Coronary Artery Disease/diagnosis, Department of Internal Medicine, Diabetes Mellitus, Diabetic Nephropathies/*diagnosis/epidemiology/etiology, Drug Utilization, Female, Frazee Lawrence A, Humans, Hypertension/diagnosis/drug therapy, Male, Middle Aged, NEOMED College of Medicine, Pfister Eugene W, Practice Guidelines as Topic, Proteinuria/diagnosis, Retrospective Studies, Samandari Seyhoon, Tanphaichitr Natthavat, Type 1/complications/drug therapy, Type 2/complications/drug therapy